These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

309 related articles for article (PubMed ID: 9334623)

  • 1. Use of repeat sextant and transition zone biopsies for assessing extent of prostate cancer.
    Epstein JI; Walsh PC; Sauvageot J; Carter HB
    J Urol; 1997 Nov; 158(5):1886-90. PubMed ID: 9334623
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Relationship between systematic biopsies and histological features of 222 radical prostatectomy specimens: lack of prediction of tumor significance for men with nonpalpable prostate cancer.
    Noguchi M; Stamey TA; McNeal JE; Yemoto CM
    J Urol; 2001 Jul; 166(1):104-9; discussion 109-10. PubMed ID: 11435833
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The percent of cores positive for cancer in prostate needle biopsy specimens is strongly predictive of tumor stage and volume at radical prostatectomy.
    Sebo TJ; Bock BJ; Cheville JC; Lohse C; Wollan P; Zincke H
    J Urol; 2000 Jan; 163(1):174-8. PubMed ID: 10604340
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Radical prostatectomy for impalpable prostate cancer: the Johns Hopkins experience with tumors found on transurethral resection (stages T1A and T1B) and on needle biopsy (stage T1C).
    Epstein JI; Walsh PC; Brendler CB
    J Urol; 1994 Nov; 152(5 Pt 2):1721-9. PubMed ID: 7523719
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Extended prostate biopsy scheme improves reliability of Gleason grading: implications for radiotherapy patients.
    King CR; McNeal JE; Gill H; Presti JC
    Int J Radiat Oncol Biol Phys; 2004 Jun; 59(2):386-91. PubMed ID: 15145152
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prostate biopsy: who, how and when. An update.
    Djavan B; Milani S; Remzi M
    Can J Urol; 2005 Feb; 12 Suppl 1():44-8; discussion 99-100. PubMed ID: 15780165
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ability of sextant biopsies to predict radical prostatectomy stage.
    Wills ML; Sauvageot J; Partin AW; Gurganus R; Epstein JI
    Urology; 1998 May; 51(5):759-64. PubMed ID: 9610589
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pathological parameters of radical prostatectomy for clinical stages T1c versus T2 prostate adenocarcinoma: decreased pathological stage and increased detection of transition zone tumors.
    Jack GS; Cookson MS; Coffey CS; Vader V; Roberts RL; Chang SS; Smith JA; Shappell SB
    J Urol; 2002 Aug; 168(2):519-24. PubMed ID: 12131301
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prediction of tumour volume and pathological stage in radical prostatectomy specimens is not improved by taking more prostate needle-biopsy cores.
    Grossklaus DJ; Coffey CS; Shappell SB; Jack GS; Cookson MS
    BJU Int; 2001 Nov; 88(7):722-6. PubMed ID: 11890243
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pathological features of prostate cancer detected on initial and repeat prostate biopsy: results of the prospective European Prostate Cancer Detection study.
    Djavan B; Mazal P; Zlotta A; Wammack R; Ravery V; Remzi M; Susani M; Borkowski A; Hruby S; Boccon-Gibod L; Schulman CC; Marberger M
    Prostate; 2001 May; 47(2):111-7. PubMed ID: 11340633
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Estimation of prostate cancer volume by multiple core biopsies before radical prostatectomy.
    Egevad L; Norberg M; Mattson S; Norlén BJ; Busch C
    Urology; 1998 Oct; 52(4):653-8. PubMed ID: 9763088
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Initial atypical diagnosis with carcinoma on subsequent prostate needle biopsy: findings at radical prostatectomy.
    Chen YB; Pierorazio PM; Epstein JI
    J Urol; 2010 Nov; 184(5):1953-7. PubMed ID: 20846684
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Utility of saturation biopsy to predict insignificant cancer at radical prostatectomy.
    Epstein JI; Sanderson H; Carter HB; Scharfstein DO
    Urology; 2005 Aug; 66(2):356-60. PubMed ID: 16040085
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Correlation of the anatomo-pathological staging of radical prostatectomy specimens with the amount of cancer in the preoperative sextant biopsy].
    Ojea Calvo A; Núñez López A; Domínguez Freire F; Alonso Rodrigo A; Rodríguez Iglesias B; Benavente Delgado J; Barros Rodríguez JM; Gómez-González MC; González Piñeiro A; Otero García M; Nogueira March JL
    Actas Urol Esp; 2003 Jun; 27(6):428-37. PubMed ID: 12918149
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prospective evaluation of prostate cancer detected on biopsies 1, 2, 3 and 4: when should we stop?
    Djavan B; Ravery V; Zlotta A; Dobronski P; Dobrovits M; Fakhari M; Seitz C; Susani M; Borkowski A; Boccon-Gibod L; Schulman CC; Marberger M
    J Urol; 2001 Nov; 166(5):1679-83. PubMed ID: 11586201
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pathologic and clinical findings to predict tumor extent of nonpalpable (stage T1c) prostate cancer.
    Epstein JI; Walsh PC; Carmichael M; Brendler CB
    JAMA; 1994 Feb; 271(5):368-74. PubMed ID: 7506797
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Increasing the number of biopsies increases the concordance of Gleason scores of needle biopsies and prostatectomy specimens.
    Divrik RT; Eroglu A; Sahin A; Zorlu F; Ozen H
    Urol Oncol; 2007; 25(5):376-82. PubMed ID: 17826653
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characterization of prostate cancer missed by sextant biopsy.
    Bak JB; Landas SK; Haas GP
    Clin Prostate Cancer; 2003 Sep; 2(2):115-8. PubMed ID: 15040873
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prospective evaluation of men with stage T1C adenocarcinoma of the prostate.
    Carter HB; Sauvageot J; Walsh PC; Epstein JI
    J Urol; 1997 Jun; 157(6):2206-9. PubMed ID: 9146616
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prostate needle biopsies: multiple variables are predictive of final tumor volume in radical prostatectomy specimens.
    Poulos CK; Daggy JK; Cheng L
    Cancer; 2004 Aug; 101(3):527-32. PubMed ID: 15274065
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.